Pharmacist Weight Management On-Demand 1h

America has a weight problem – over 40% of the US is obese and over 70% are overweight. Diet and exercise are the cornerstones of treatment; however, new medications are coming to the market. The recent STEP Trial evaluated injectable semaglutide for weight loss. This course will evaluate the trial and if there is now an easy step in weight loss.

Learning Objectives

Upon successful completion of this application-based course, pharmacists and pharmacy students should be able to:
1. Describe the mechanism of action and clinical pearls of semaglutide.
2. Compare and contrast semaglutide with other available glucagon-like peptide-1 receptor agonists.
3. Discuss clinical trial data on semaglutide’s effect on weight outcomes.
4. Identify patients who are candidates to receive semaglutide for weight loss.
5. Develop a conclusion for the clinical appropriateness of care based on a clinical trial.

Faculty

Abby Winter, PharmD, MPA, BCACP

Clinical Assistant Professor
University of Washington

Disclosures:

Abby Winter has no relevant financial relationships with ineligible companies to disclose.

Course Details